List of companies in Facit (Fight Against Cancer Innovation Trust)'s investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Biotechnology company using alpha particle emitting medical isotopes in targeted radiotherapy for cancer. | ||||||
Developer of surgical instruments designed to improve medical procedures. The company's instruments are intended to reduce the risk of complications, cost, and operative time associated with the use of devices in minimally invasive surgeries, enabling patients to get increased safety, surgical efficiency and reducing hospital costs. | ||||||
Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain. | ||||||
Bridge7 is a company that uses an advanced Artificial Intelligence to detect and automate the quality, efficiency, and consistency of cancer treatments | ||||||
Replica Analytics is a provider of Replica Synthesis, a software solution that ingests data and builds synthesis models to generate synthetic datasets. | ||||||
HyIvy Health offers a pelvic rehabilitation device with trackable data for women recovering from pelvic diseases and surgeries. | ||||||
Developer of ultrasound technology intended to provide non-invasive surgery. The company's technology uses focused ultrasound to treat symptomatic uterine fibroids and also precisely target and destroy cancer deep within the body, enabling medical professionals to provide incision-less surgical treatments to patients. | ||||||
Developer of novel drugs intended to treat central nervous system disorders and challenging bacterial infections. The company's drug design platform identifies new therapies for rare disorders of the central nervous system and multidrug-resistant gram-negative bacterial infections. | ||||||
DNAstack is a Toronto-based company founded in 2014 by Marc Fiume, James Vlasblom, Miro Cupak and Ryan Cook. | ||||||
Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody | ||||||
Cellular Analytics is a developer of a microfluidic platform designed to optimize the detection of rare circulating tumor cells. |
